About Us

FluoretiQ Limited

FluoretiQ Limited (FQ) was founded to solve the £1.1 Bn problem of using broad spectrum antibiotics as an alternative for accurate diagnosis of infection.

We have developed NANOPLEX™ technology to ensure that Primary Healthcare professionals can prescribe the most effective antibiotic treatment from day one.

Saving Time

Today’s tools for the identification of bacterial infection can often leave patients waiting days for accurate diagnosis and treatment. Our technology platform is 200x faster and can identify infection in less than 15 minutes.

Saving Money

The direct and indirect cost of using empirical antibiotic treatments worldwide has been estimated at £1.1 Billion. Our testing enables clinicians to effectively treat patients at their first consultation.

Saving Lives

Delays in effective diagnosis lead to multiple GP visits, long-term antibiotic use, and hospitalisation. With rapid testing we provide critical information when you need it most- the point of care.

  • Learn More

Meet Our Team

Neciah Dorh
Neciah Dorh, CEO

Neciah leads our company’s vision to safeguard antibiotic use with rapid bacterial diagnostics. Since co-founding the company in 2017, he has attracted grant and investment funding opportunities and forged long-term strategic partnerships to ensure patients receive the most effective antibiotic first time; Saving Time, Saving Money and most importantly Saving Lives.

Josephine Dorh, CTO

Josephine is a founder and co-inventor of FluoretiQ’s NANOPLEX™ technology, responsible for early development of concept to our prototype systems. She now leads our multi-disciplinary R&D team to translate our expertise into a fast and accurate diagnostic platform

Josephine Dorh
James Preece
James Preece, Product Manager

James is responsible for understanding global healthcare markets to inform FluoretiQ’s business development, commercialisation and tactical marketing strategies. He is able to translate his experience within SME, consultancy and drug discovery environments to ensure NANOPLEX™ is part of the solution to tackling Antimicrobial Resistance.

Mathew Kyriakides, Assay Development Scientist

Mathew uses his extensive knowledge of assay development and validation to ensure NANOPLEX™ is a fast, simple and consistent test for bacterial detection. His experience working in partnership with the EU’s IMI and GMP compliant environments are utilised as he continues his ambition to make a significant contribution to antimicrobial resistance.

Mathew Kyriakides
Jean-Baptiste Vendeville, Organic Chemist

JB is our resident glycan expert and responsible for the design of the unique chemical building blocks used by NANOPLEX™. He brings his multi-disciplinary background and knowledge in complex synthetic routes to deliver novel solutions for our R&D programme.

Henry Newman, Assay Development Intern

Henry is our Assay Development Intern who supports Mat in validation of NANOPLEX™. Since his MSc at the University of Bristol, he has already become an integral member of the R&D team.

Abraham Mauleon Amieva, Data Systems Analyst Intern

Abraham is our Data Systems Analyst Intern who joins FluoretiQ via the University of Bristol SME Covid-19 fund. His role is focused on training and optimising the machine learning algorithms used by NANOPLEX™ for robust probe detection.

Charlotte Colenso, KTN Computational Chemist

Charlotte is a computational chemist at the University of Bristol and has been awarded a BBSRC Flexible Talent Mobility Account (FTMA) in partnership with FluoretiQ. The project will apply state-of-the-art computational approaches to identify and validate new glycan targets for NANOPLEX™

Logo
Martin Cryan, Co-founder and Scientific Advisor

Martin is a Professor of Applied Electromagnetics at University of Bristol with 30 years experience in electronic and photonic device research and development

Annie Brooking, Director of Marketing

Annie is an experienced executive and non-executive Director, with 27 years as a CEO of high tech companies. With an impressive 19 products successfully brought to market, she consults with the product team to guide our marketing and product launch strategy.

Annie Brooking
Logo
Dr James Spencer, Scientific Advisor

Jim is a Reader in Microbiology at University of Bristol and a co-investigator on 2 collaborative projects with FluoretiQ. His work in microbiology and AMR drives continuous improvement of the FCD technology.

Carmen Galan, Scientific Advisor

Carmen is a Professor of Organic and Biological Chemistry at University of Bristol and currently Principal investigator on 2 collaborative projects with FluoretiQ. Her work in synthetic chemistry underpins the FCD technology.

Carmen Galan
Vicki Lamch
Vicki Lamch (Pyramis Solutions Ltd.), Finance Director

Vicki started her career within the Tech industry in 2002, where she focused on managing SME financial affairs.

She is a Certified Accountant (ACCA) and stays involved with ACCA as the Chair for the Bristol Regional Panel and is a member of the Global Tech Forum.

Also, a Qualified Coach, NLP Practitioner, Accredited in DISC Personality Profiling and trained in Motivational Maps, Vicki brings those skills & experiences together to be a future focused strategic advisor to local businesses supporting in a Financial Director capacity.

Meet Our Team

Neciah Dorh
Neciah Dorh, CEO

Neciah leads our company’s vision to safeguard antibiotic use with rapid bacterial diagnostics. Since co-founding the company in 2017, he has attracted grant and investment funding opportunities and forged long-term strategic partnerships to ensure patients receive the most effective antibiotic first time; Saving Time, Saving Money and most importantly Saving Lives.

Josephine Dorh
Josephine Dorh, CTO

Josephine is a founder and co-inventor of FluoretiQ’s NANOPLEX™ technology, responsible for early development of concept to our prototype systems. She now leads our multi-disciplinary R&D team to translate our expertise into a fast and accurate diagnostic platform.

James Preece
James Preece, Product Manager

James is responsible for understanding global healthcare markets to inform FluoretiQ’s business development, commercialisation and tactical marketing strategies. He is able to translate his experience within SME, consultancy and drug discovery environments to ensure NANOPLEX™ is part of the solution to tackling Antimicrobial Resistance.

Mathew Kyriakides
Mathew Kyriakides, Lead Microbiologist

Mathew uses his extensive knowledge of assay development and validation to consolidate NANOPLEX™ into a fast, simple and consistent test for bacterial detection. His experience working in partnership with the EU’s IMI and GMP compliant environments are utilised as he continues his ambition to make a significant contribution to antimicrobial resistance.

Martin Cryan, Co-founder and Scientific Advisor

Martin is a Professor of Applied Electromagnetics at University of Bristol with 30 years experience in electronic and photonic device research and development

Annie Brooking
Annie Brooking, Director of Marketing

Annie is an experienced executive and non-executive Director, with 27 years as a CEO of high tech companies. With an impressive 19 products successfully brought to market, she consults with the product team to guide our marketing and product launch strategy.

Carmen Galan
Carmen Galan, Scientific Advisor

Carmen is a Professor of Organic and Biological Chemistry at University of Bristol and currently Principal investigator on 2 collaborative projects with FluoretiQ. Her work in synthetic chemistry underpins the FCD technology.

Dr James Spencer, Scientific Advisor

Jim is a Reader in Microbiology at University of Bristol and a co-investigator on 2 collaborative projects with FluoretiQ. His work in microbiology and AMR drives continuous improvement of the FCD technology.

Vicki Lamch
Vicki Lamch (Pyramis Solutions Ltd.), Finance Director

Vicki started her career within the Tech industry in 2002, where she focused on managing SME financial affairs.

She is a Certified Accountant (ACCA) and stays involved with ACCA as the Chair for the Bristol Regional Panel and is a member of the Global Tech Forum.

Also, a Qualified Coach, NLP Practitioner, Accredited in DISC Personality Profiling and trained in Motivational Maps, Vicki brings those skills & experiences together to be a future focused strategic advisor to local businesses supporting in a Financial Director capacity.

Menu